Efficacy RENO Study Results of Oral Vinorelbine or Etoposide with Cisplatin Et Chemo-Radiation in Stage III NSCLC. SLCG 10/02

被引：0

作者：

Isla, Dolores ^{[1
]}

De las Penas, Ramon ^{[2
]}

Marse, Raquel ^{[3
]}

Insa Molla, Amelia ^{[4
]}

Martinez-Banaclocha, Natividad ^{[5
]}

Moran, Teresa ^{[6
]}

Mut, Pilar ^{[7
]}

Angeles Sala, Maria ^{[8
]}

Massuti, Bartomeu ^{[9
]}

Ortega Granados, Ana Laura ^{[10
]}

Miguel Jurado, Jose ^{[11
]}

Artal Cortes, Miguel ^{[12
]}

Vazquez, Maria ^{[13
]}

Gutierrez, Vanesa ^{[14
]}

Diz Tain, Pilar ^{[15
]}

Gomez-Codina, Jose ^{[16
,17
]}

Maestu Maiques, Inma ^{[18
]}

Camps, Carlos ^{[19
]}

Vinolas Segarra, Nuria ^{[20
]}

Ponce Aix, Santiago ^{[21
]}

De Mon Soto, Melchor Alvarez ^{[22
]}

Garcia Gomez, Ramon ^{[23
]}

Provencio, Mariano ^{[24
]}

机构：

[1] Univ Hosp Clin Lozano Blesa, Med Oncol, Zaragoza, Spain

[2] Prov Hosp Castellon, Med Oncol, Castellon de La Plana, Spain

[3] Univ Hosp Son Espases, Med Oncol, Palma de Mallorca, Spain

[4] Univ Hosp Clin Valencia, Med Oncol, Valencia, Spain

[5] Gen Univ Hosp Elche, Med Oncol, Elche, Spain

[6] Hosp Badalona Germans Trias & Pujol, Med Oncol, Badalona, Spain

[7] Hosp Son Llatzer, Med Oncol, Palma de Mallorca, Spain

[8] Univ Hosp Basurto, Med Oncol, Bilbao, Spain

[9] Alicante Univ Hosp, Med Oncol, Alicante, Spain

[10] Complejo Hosp Jaen, Med Oncol, Jaen, Spain

[11] Univ Hosp San Cecilio, Med Oncol, Granada, Spain

[12] Univ Hosp Miguel Servet, Med Oncol, Zaragoza, Spain

[13] Univ Hospitality Complex Santiago, Med Oncol, Santiago De Compostela, Spain

[14] Reg Univ Hosp Malaga, Med Oncol, Malaga, Spain

[15] Assistent Complex Leon, Med Oncol, Leon, Spain

[16] Univ Valencia, Med Oncol, Valencia, Spain

[17] Polythecn Hosp La Fe, Valencia, Spain

[18] Univ Hosp Doctor Peset, Med Oncol, Valencia, Spain

[19] Gen Univ Valencia, Consorcio Hosp, Med Oncol, Valencia, Spain

[20] Univ Hosp Clin Barcelona, Med Oncol, Barcelona, Spain

[21] Univ Hosp 12 Octubre, Med Oncol, Madrid, Spain

[22] Univ Hosp Principe Asturias, Med Oncol, Alcala De Henares, Spain

[23] Univ Hosp Gregorio Maranon, Madrid, Spain

[24] Univ Hosp Puerta de Hierro, Med Oncol, Majadahonda, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

Locally advanced NSCLC; Oral Vinorelbine; chemotherapy; Radiotherapy;

D O I：

10.1016/j.jtho.2016.11.421

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA06.09

引用

页码：S373 / S374

页数：2

共 43 条

[31] ORAL VINORELBINE (NVBO) AND CISPLATIN (P) WITH CONCOMITANT RADIOTHERAPY (RT) FOLLOWED BY EITHER CONSOLIDATION THERAPY WITH NVBO AND P PLUS BEST SUPPORTIVE CARE (BSC) OR BSC ALONE IN STAGE (ST) III NON SMALL CELL LUNG CANCER (NSCLC): PRELIMINARY RESULTS OF A PHASE III STUDY
Flentje, M.
Chemaissani, A.
Kollmeier, J.
Andreas, S.
Staar, S.
Klautke, G.
Fietkau, R.
Vaissiere, N.
Osowski, S.
Huber, R.
ANNALS OF ONCOLOGY, 2010, 21 : 125 - 125
[32] Phase II study of induction chemotherapy (ICT) with gemcitabine (G) and vinorelbine (V) followed by concurrent chemoradiation therapy (CCRT) with oral etoposide (E) and cisplatin (P) for inoperable stage IIIA/B non-small cell lung cancer (NSCLC).
Lee, DH
Han, JY
Cho, KH
Chun, JH
Lee, HG
Lee, JJ
Pyo, HR
Yoon, SJ
Zo, JI
Lee, JS
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 679S - 679S
[33] Cisplatin plus gemcitabine with or without vinorelbine as neoadjuvant therapy for radically treatable stage III non small cell lung cancer (NSCLC).: Preliminary results of a randomised study of the GON (Grupo Oncologico del Norte de Espana).
Villanueva, N
Esteban, E
Fra, J
De Sande, J
Mareque, B
Uña, E
Muñiz, I
Fernández, Y
Buesa, J
Lacave, A
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 658S - 658S
[34] GILT study: Oral vinorelbine (NVBo) and cisplatin (P) with concomitant radiotherapy (RT) followed by either consolidation (C) with NVBo plus P plus best supportive care (BSC) or BSC alone in stage (st) III non-small cell lung cancer (NSCLC): Final results of a phase (ph) III study
Huber, Rudolf M.
Engel-Riedel, Walburga
Kollmeier, Jens
Andreas, Stefan
Staar, Susanne
Klautke, Gunther
Fietkau, Rainer
Vaissiere, Nathalie
Osowski, Susanne
Flentje, Michael
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[35] Cisplatin plus gemcitabine with or without vinorelbine as neo-adjuvant therapy for radically treatable stage III Non small cell lung cancer (NSCLC).: Preliminary results of a randomised study of the GON (Grupo Oncologico del Norte de Espana)
Esteban, E
Fernández, Y
Vieitez, J
Villanueva, N
De Sande, J
Fra, J
Muñiz, I
Palacio, I
Fernández, J
Lacave, A
LUNG CANCER, 2005, 49 : S40 - S40
[36] An open-label, randomized, multicentric study, to assess the safety and efficacy of h-R3 monoclonal antibody against EGF-receptor in combination with chemo-radiation therapy or radiation therapy alone in patients with advanced (stage III or IVA) head and neck cancer
Reddy, Krishnamurthy
Lokesh, Viswanath
Vidyasagar, S.
Rao, Koteshwar
Shenoy, Ashok
Thimmaiah, Naveen
Babu, Govinda
Dr, Nanjundappa
Joseph, Bindhu
Bonnathiya, Ravikiran
Bapsy, P.
CANCER RESEARCH, 2009, 69
[37] Multivariate analysis of prognostic variables associated with survival from a phase III study of cisplatin (P) plus etoposide (E) plus chest radiation (XRT) with or without consolidation docetaxel (D) in patients with unresectable stage III non-small cell lung cancer (NSCLC)
Ademuyiwa, F. O.
Breen, T. E.
Johnson, C.
White, A.
Yiannoutsos, C.
Hanna, N.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[38] Phase III study of cisplatin (P) plus etoposide (E) with concurrent chest radiation (XRT) followed by docetaxel (D) vs. observation in patients (pts) with stage III non-small cell lung cancer (NSCLC): An interim toxicity analysis of consolidation therapy.
Bedano, P. M.
Neubauer, M.
Ansari, R.
Govindan, R.
Einhorn, L. H.
Bruetman, D.
White, A.
Breen, T.
Juliar, B.
Hanna, N.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 374S - 374S
[39] Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01-24/USO-023-Updated results
Mina, L. A.
Neubauer, M. A.
Ansari, R. H.
Govindan, R.
Einhorn, L. H.
Fisher, W.
Bruetman, D.
Chowhan, N. M.
Johnson, C.
Hanna, N. H.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[40] FINAL RESULTS OF A RANDOMIZED, DOUBLE-BLIND PHASE II STUDY TO COMPARE NITROGLYCERIN (N) PLUS ORAL VINORELBINE (NVBO) PLUS CISPLATIN (C) WITH PLACEBO (P) PLUS NVBO PLUS C IN PATIENTS (PTS) WITH STAGE IIIB/IV NON-SMALL CELL LUNG CANCER (NSCLC)
Reck, M.
Meyer, A.
Hartwigsen, D.
Schaeper, C.
Skock-Lober, R.
Bier, A.
Huebner, G.
Gereke, U.
Rose, C.
Held, C. P.
ANNALS OF ONCOLOGY, 2012, 23 : 409 - 410

← 1 2 3 4 5 →